Low concentrations of amitriptyline inhibit nicotinic receptors in unmyelinated axons of human peripheral nerve.
OBJECTIVE
Amitriptyline is often prescribed as a first-line treatment for neuropathic pain but its precise mode of analgesic action remains uncertain. Amitriptyline is known to inhibit voltage-dependent ion channels and also to act as an antagonist at ligand-gated ion channels, such as nicotinic acetylcholine receptors (nAChRs). In the present study, we tested the effect of amitriptyline on nicotinic responses of unmyelinated axons in isolated segments of human peripheral nerve. In particular, a comparison was made between the concentrations of amitriptyline necessary for inhibition of nAChRs and those required for inhibition of the compound C-fibre action potential.


METHODS
Isolated axon fascicles were prepared from short segments of human sural nerve, and multiple measures of axonal excitability were recorded using computer-controlled threshold tracking software.


RESULTS
Amitriptyline (EC(50) 2.6 microM) reduced the nicotine-induced increase in C-fibre excitability but only slightly altered the amplitude and latency to onset of the compound action potential. In contrast, tetrodotoxin produced a clear reduction in the amplitude and a prolongation of action potential onset latency but was without effect on the nicotine-induced increase in axonal excitability.


CONCLUSIONS
These data demonstrate that low concentrations of amitriptyline suppress the response of human peripheral C-type axons to nicotine by directly inhibiting nAChRs. Blockade of tetrodotoxin-sensitive, voltage-dependent sodium channels does not contribute to this effect. An inhibitory action of amitriptyline on nAChRs in unmyelinated nociceptive axons may be an important component of amitriptyline's therapeutic effect in the treatment of neuropathic pain.
Freysoldt
A
A
Institute of Physiology, University of Munich, Munich, Germany.
Fleckenstein
J
J
Lang
P M
PM
Irnich
D
D
Grafe
P
P
Carr
R W
RW
D000200:Action Potentials / Q000187:drug effects; D000639:Amitriptyline / Q000494:pharmacology*; D018712:Analgesics, Non-Narcotic / Q000494:pharmacology*; D001369:Axons / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D066298:In Vitro Techniques; D036421:Nerve Fibers, Unmyelinated / Q000187:drug effects / Q000502:physiology; D009538:Nicotine / Q000494:pharmacology; D018722:Nicotinic Agonists / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000494:pharmacology*; D011978:Receptors, Nicotinic / Q000502:physiology*; D013497:Sural Nerve / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D013779:Tetrodotoxin / Q000494:pharmacology
D018712:Analgesics, Non-Narcotic; D018722:Nicotinic Agonists; D018733:Nicotinic Antagonists; D011978:Receptors, Nicotinic; D000639:Amitriptyline; D013779:Tetrodotoxin; D009538:Nicotine
J Neural Transm Gen Sect. 1991;85(1):31-9
1867836
J Pharmacol Exp Ther. 1963 Feb;139:201-7
13974071
Br J Pharmacol. 1992 Mar;105(3):657-66
1378342
J Neurophysiol. 2004 Feb;91(2):1025-35
14762152
J Neurophysiol. 1993 Jul;70(1):397-405
8103089
Toxicon. 2006 Dec 1;48(7):810-29
16979678
Synapse. 1998 Jul;29(3):248-56
9635895
J Appl Physiol. 1952 Mar;4(9):745-52
14917620
J Neurophysiol. 2001 Oct;86(4):1773-82
11600638
J Neuroimmunol. 1998 Jan;81(1-2):31-7
9521603
Pain. 1992 May;49(2):205-219
1535121
Clin Pharmacokinet. 1985 May-Jun;10(3):257-68
3893842
Exp Neurol. 2006 Aug;200(2):480-5
16674943
J Neurophysiol. 2003 May;89(5):2441-8
12611975
J Pharmacol Exp Ther. 2007 Jan;320(1):354-64
17005919
Neuroscience. 2005;134(4):1399-411
16039795
Brain Res Rev. 2006 Aug;51(2):240-64
16388853
Brain Res. 1993 Jul 16;617(1):37-42
8374742
J Neurophysiol. 2004 Apr;91(4):1482-91
14657192
Neuropharmacology. 2003 Dec;45(7):964-76
14573389
Pharmacol Biochem Behav. 1987 Jan;26(1):153-8
2951743
Anesth Analg. 2007 May;104(5):1256-64, tables of contents
17456683
Expert Opin Investig Drugs. 2005 Oct;14(10):1191-8
16185161
J Neurosci. 1996 Dec 15;16(24):7892-901
8987817
Muscle Nerve. 2007 Aug;36(2):172-82
17487863
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005454
17943857
J Pharmacol Exp Ther. 2000 Mar;292(3):1015-23
10688618
Nature. 1999 Apr 29;398(6730):805-10
10235262
Muscle Nerve. 1998 Feb;21(2):137-58
9466589
J Neurophysiol. 2003 Nov;90(5):3295-303
12878715
Mol Neurobiol. 2007 Apr;35(2):160-74
17917105
Ann N Y Acad Sci. 2006 Nov;1088:164-86
17192564
Life Sci. 2003 Dec 26;74(6):675-96
14654162
Exp Brain Res. 1991;86(2):414-20
1756814
Muscle Nerve. 2007 Jun;35(6):812
17415750
Neurosci Res. 2004 Feb;48(2):139-45
14741388
Neuroscience. 2002;112(1):23-38
12044469
Brain Res. 1998 Nov 2;809(2):238-45
9853116
Anesthesiology. 2002 Jan;96(1):109-16
11753010
Int J Biochem Cell Biol. 2006;38(8):1254-76
16520081
J Physiol. 1960 Mar;150:501-14
13817839
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17880-4
17101979
Anesthesiology. 2001 Jan;94(1):137-44
11135733
Pain. 2004 Jul;110(1-2):166-74
15275764
Eur J Pharmacol. 1997 Jul 2;330(1):15-25
9228410
J Pain. 2007 Apr;8(4):315-24
17175203
Anesthesiology. 2008 Apr;108(4):714-21
18362604
Arch Pharm Res. 2008 Feb;31(2):178-82
18365687
Muscle Nerve. 1992 Dec;15(12):1340-4
1470198
Neuroscience. 2002;115(1):1-5
12401316
Pharmacol Biochem Behav. 2005 Jan;80(1):135-43
15652389